Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
HS-110 (Viagenpumatucel-L) is a tumor cell vaccine comprised of irradiated tumor cells expressing recombinant gp96-Ig, which is secreted and induces an immune response to endogenous tumor cells (NCI Drug Dictionary).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Cyclophosphamide + HS-110||Cyclophosphamide HS-110||0||1|
|HS-110 + HS-130||HS-110 HS-130||0||1|
|HS-110 + Nivolumab||HS-110 Nivolumab||1||0|